Back to ASND
GOLDMAN SACHS GROUP INC → ASND
GOLDMAN SACHS GROUP INC ASND Position History
Ascendis Pharma A/S • Healthcare
Quarters held
18
Latest value
$368K
Q2 2026
Peak value
$121M
First seen
Q1 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2025 | $83.7M |
| Q1 2025 | $7.6M |
| Q2 2025 | $83.5M |
| Q2 2025 | $1.8M |
| Q2 2025 | $9.2M |
| Q2 2025 | $231K |
| Q3 2025 | $120M |
| Q3 2025 | $9.8M |
| Q3 2025 | $1.7M |
| Q4 2025 | $8.5M |
| Q4 2025 | $118.7M |
| Q4 2025 | $118.7M |
| Q4 2025 | $8.5M |
| Q1 2026 | $121M |
| Q1 2026 | $8.5M |
| Q2 2026 | $114M |
| Q2 2026 | $34.9M |
| Q2 2026 | $368K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $368K | 1.4K | — | — |
| Q2 2026 | $34.9M | 130.7K | — | — |
| Q2 2026 | $114M | 427.4K | — | — |
| Q1 2026 | $8.5M | 37.3K | — | — |
| Q1 2026 | $121M | 528.9K | — | — |
| Q4 2025 | $8.5M | 40.1K | — | — |
| Q4 2025 | $118.7M | 556.7K | — | — |
| Q4 2025 | $118.7M | 556.7K | — | — |
| Q4 2025 | $8.5M | 40.1K | — | — |
| Q3 2025 | $1.7M | 8.3K | — | — |
| Q3 2025 | $9.8M | 49.3K | — | — |
| Q3 2025 | $120M | 603.7K | — | — |
| Q2 2025 | $231K | 1.3K | — | — |
| Q2 2025 | $9.2M | 53.4K | — | — |
| Q2 2025 | $1.8M | 10.4K | — | — |
| Q2 2025 | $83.5M | 483.5K | — | — |
| Q1 2025 | $7.6M | 48.5K | — | — |
| Q1 2025 | $83.7M | 537.0K | — | — |
Other funds holding ASND
$290.4M
$175.4M
$137.1M